FIRE1 is a connected medical device solutions company focused on developing a heart failure management platform that enables patient self-management and reduces healthcare burdens.

Elucid is a Boston-based medical technology company that has developed AI-powered non-invasive diagnostic tools for cardiovascular risk evaluation, including the FDA-cleared PlaqueIQ software for characterizing arterial plaque and non-invasive measurement of fractional flow reserve.